Terms: = Ovarian cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Diagnosis
54 results:
1. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
Němejcová K; Šafanda A; Bártů MK; Michálková R; Drozenová J; Fabian P; Hausnerová J; Laco J; Matěj R; Méhes G; Škapa P; Stružinská I; Dundr P
Diagn Pathol; 2023 Feb; 18(1):32. PubMed ID: 36855066
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathologic Features and the Loss of ARID1A Expression in ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.
Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A
Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965
[TBL] [Abstract] [Full Text] [Related]
3. Postchemotherapy Endometrioid to Gastrointestinal Histotype Shift in Recurrent Endometrial Carcinoma.
Arciuolo D; Travaglino A; Santoro A; Pedone Anchora L; Inzani F; Angelico G; D'Alessandris N; Scaglione G; Valente M; Raffone A; Fanfani F; Zannoni GF
Int J Gynecol Pathol; 2022 Nov; 41(6):583-587. PubMed ID: 36302189
[TBL] [Abstract] [Full Text] [Related]
4. Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy.
Anderson KG; Oda SK; Bates BM; Burnett MG; Rodgers Suarez M; Ruskin SL; Greenberg PD
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35264436
[TBL] [Abstract] [Full Text] [Related]
5. Intestinal-type mucinous ovarian carcinoma arising from a seromucinous precursor lesion.
Santoro A; D'Alessandris N; Travaglino A; Arciuolo D; Inzani F; Angelico G; Scaglione G; Valente M; Raffone A; Zannoni GF
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1263-1267. PubMed ID: 35253183
[TBL] [Abstract] [Full Text] [Related]
6. Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials-a case report.
Kaur K; Shah A; Gandhi J; Trivedi P
J Egypt Natl Canc Inst; 2022 Feb; 34(1):9. PubMed ID: 35224708
[TBL] [Abstract] [Full Text] [Related]
7. Accurate Distinction of ovarian Clear Cell From Endometrioid Carcinoma Requires Integration of Phenotype, Immunohistochemical Predictions, and Genotype: Implications for Lynch Syndrome Screening.
Rodriguez M; Kang EY; Farrington K; Cook LS; Le ND; Karnezis AN; Lee CH; Nelson GS; Terzic T; Lee S; Köbel M
Am J Surg Pathol; 2021 Nov; 45(11):1452-1463. PubMed ID: 34534137
[TBL] [Abstract] [Full Text] [Related]
8. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature.
Ravichandaran A; Lakshmanan A; Kurian A; Prasad S
Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265
[TBL] [Abstract] [Full Text] [Related]
9. Diagnostic Pitfalls Related to Morular Metaplasia in Endometrioid Carcinoma: An Underestimated Issue.
Travaglino A; Raffone A; Gencarelli A; Saracinelli S; Zullo F; Insabato L
Pathobiology; 2021; 88(3):261-266. PubMed ID: 33887731
[TBL] [Abstract] [Full Text] [Related]
10. FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant β-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas.
Weisman P; Park KJ; Xu J
Int J Gynecol Pathol; 2022 Mar; 41(2):126-131. PubMed ID: 33811207
[TBL] [Abstract] [Full Text] [Related]
11. Mesenteric and Retroperitoneal Mucinous Cystic Neoplasms: A Case Series.
Van Treeck BJ; Horton RK; Lee HE; Rosty C; Pai RK; Graham RP
Int J Surg Pathol; 2021 Sep; 29(6):606-614. PubMed ID: 33736504
[No Abstract] [Full Text] [Related]
12. Evaluation of cell blocks from effusion specimens in Gynecologic Oncopathology: An experience of 220 cases, diagnosed at a Tertiary cancer Referral Center.
Rekhi B; Karmarkar S; Gupta C; Deodhar KK; Menon S; Pathuthara S; Maheshwari A; Shylasree TS; Gupta S
Indian J Pathol Microbiol; 2020; 63(3):427-434. PubMed ID: 32769333
[TBL] [Abstract] [Full Text] [Related]
13. Histological clues to the diagnosis of metastasis to the breast from extramammary malignancies.
Lee AHS; Hodi Z; Soomro I; Sovani V; Abbas A; Rakha E; Ellis IO
Histopathology; 2020 Aug; 77(2):303-313. PubMed ID: 32396659
[TBL] [Abstract] [Full Text] [Related]
14. Advanced stage primary mucinous ovarian carcinoma. Where do we stand ?
Nasioudis D; Albright BB; Ko EM; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Latif NA
Arch Gynecol Obstet; 2020 Apr; 301(4):1047-1054. PubMed ID: 32185553
[TBL] [Abstract] [Full Text] [Related]
15. The Frequency and Prognostic Significance of the Histologic Type in Early-stage ovarian Carcinoma: A Reclassification Study by the Spanish Group for ovarian cancer Research (GEICO).
Leskela S; Romero I; Cristobal E; Pérez-Mies B; Rosa-Rosa JM; Gutierrez-Pecharroman A; Santón A; Gonzalez BO; López-Reig R; Hardisson D; Vera-Sempere F; Illueca C; Vieites B; López-Guerrero JA; Palacios J; Poveda A
Am J Surg Pathol; 2020 Feb; 44(2):149-161. PubMed ID: 31498173
[TBL] [Abstract] [Full Text] [Related]
16. Tumor-to-tumor metastasis from appendiceal adenocarcinoma to an ovarian mature teratoma, mimicking malignant transformation of a teratoma: a case report.
Yano M; Katoh T; Hamaguchi T; Kozawa E; Hamada M; Nagata K; Yasuda M
Diagn Pathol; 2019 Aug; 14(1):88. PubMed ID: 31409389
[TBL] [Abstract] [Full Text] [Related]
17. MORPHOPHENOTYPIC CHARACTERISTICS OF ovarian SEROUS BORDERLINE TUMORS.
Munjishvili V; Barabadze E; Musashvili T; Gachechiladze M; Burkadze G
Georgian Med News; 2019 May; (290):20-25. PubMed ID: 31322508
[TBL] [Abstract] [Full Text] [Related]
18. Primary endocervical gastric-type adenocarcinoma: a clinicopathologic and immunohistochemical analysis of 23 cases.
Lu S; Shen D; Zhao Y; Kang N; Wang X
Diagn Pathol; 2019 Jul; 14(1):72. PubMed ID: 31279344
[TBL] [Abstract] [Full Text] [Related]
19. Role of HNF1β in the differential diagnosis of yolk sac tumor from other germ cell tumors.
Rougemont AL; Tille JC
Hum Pathol; 2018 Nov; 81():26-36. PubMed ID: 29753846
[TBL] [Abstract] [Full Text] [Related]
20. SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): A series of seven cases.
Schmoeckel E; Kirchner T; Mayr D
Pathol Res Pract; 2018 Mar; 214(3):426-430. PubMed ID: 29487003
[TBL] [Abstract] [Full Text] [Related]
[Next]
